Jane Grove

(Former)

1 - 6 out of 6Page size: 10

Publications

  1. 2020
  2. E-pub ahead of print

    Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolome

    Angela Taylor, Lorna Gilligan, Zaki Hassan-Smith, Jane Grove, Wiebke Arlt & 1 others, Jeremy Tomlinson, 16 Apr 2020, In: Alimentary Pharmacology & Therapeutics.

    Research output: Contribution to journal › Article › peer-review

  3. 2010
  4. Published

    Testing double mutants of the enzyme nitroreductase for enhanced cell sensitisation to prodrugs: Effects of combining beneficial single mutations

    Simon Vass, Chris Guise, Jane Grove, Eva Hyde & Peter Searle, 15 Jan 2010, In: Biochemical Pharmacology. 79, 2, p. 102-111 10 p.

    Research output: Contribution to journal › Article › peer-review

  5. 2007
  6. Published

    Kinetic and Structural Characterisation of Escherichia coli Nitroreductase Mutants Showing Improved Efficacy for the Prodrug Substrate CB1954

    Andrew Lovering, Scott White, Jane Grove, Peter Searle & Eva Hyde, 27 Apr 2007, In: Journal of Molecular Biology. 368, 2, p. 481-492 12 p.

    Research output: Contribution to journal › Article

  7. Published

    Direct positive selection for improved nitroreductase variants using SOS triggering of bacteriophage lambda lytic cycle

    Jane Grove, Eva Hyde & Peter Searle, 1 Apr 2007, In: Gene Therapy. 14, 8, p. 690-698 9 p.

    Research output: Contribution to journal › Article › peer-review

  8. 2004
  9. Published

    Nitroreductase: A prodrug-activating enzyme for cancer gene therapy

    Peter Searle, Andrew Lovering, Jane Grove, Chris Guise, Nicholas James, Vivien Mautner, Lawrence Young, David Kerr, Scott White & Eva Hyde, 1 Nov 2004, In: Clinical and Experimental Pharmacology and Physiology. 31, 11, p. 811-816 6 p.

    Research output: Contribution to journal › Article › peer-review

  10. 2003
  11. Published

    Generation of Escherichia coli nitroreductase mutants conferring improved cell sensitization to the prodrug CB1954

    Jane Grove, Andrew Lovering, Chris Guise, Scott White, Eva Hyde & Peter Searle, 1 Sep 2003, In: Cancer Research. 63, 17, 5532.

    Research output: Contribution to journal › Article › peer-review